Dianthus Therapeutics | MGTA - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 412.27B 348.97B 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
IQVIA Holdings USD 13.99B 105M 2026-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 603M 7M 2026-03
Organigram Holdings CAD 62.52M 13.88M 2025-12
Organon & Co USD 8.55B 75M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 33.16M 3.52M 2026-03
Qiagen NV USD 1.65B 15.23M 2025-12
Revvity USD 2.63B 836K 2026-03
Sartorius EUR 3.34B 152.8M 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 12.41B 67.1M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03